Neonatal blue light phototherapy and melanocytic nevi: A twin study

Pediatrics

Volumn 128, Issue 4, 2011, Pages

  Csoma, Zsanett ^a   Tóth Molnár, Edit ^b   Balogh, Klára ^a   Polyánka, Hilda ^a   Orvos, Hajnalka ^a   Ócsai, Henriette ^a   Kemény, Lajos ^a   Széll, Márta ^a   Oláh, Judit ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Novotalex Ltd   (Hungary)

Author keywords

Benign pigmented ocular lesions; Cutaneous melanocytic nevi; MC1R and HAL polymorphisms; Neonatal blue light phototherapy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BENIGN PIGMENTED UVEAL LESION; BLUE LIGHT; BLUE LIGHT PHOTOTHERAPY; CHILD; CROSS-SECTIONAL STUDY; DIZYGOTIC TWINS; GENE; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HISTIDINE AMMONIA LYASE GENE; HUMAN; MAJOR CLINICAL STUDY; MELANOCORTIN 1 RECEPTOR GENE; MELANOCYTIC NEVUS; MONOZYGOTIC TWINS; PHOTOTHERAPY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN EXAMINATION; SUN EXPOSURE; UVEA DISEASE;

EID: 80053490154     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0292     Document Type: Article

References (43)

1. Csoma Z, Erdei Z, Bartusek D, et al. The prevalence of melanocytic naevi among schoolchildren in South Hungary. J Eur Acad Dermatol Venereol. 2008;22(12):1412-1422
2. Carli P, Biggeri A, Nardini P, Giannotti B. Sun exposure and large numbers of common and atypical melanocytic naevi: an analytical study in a southern European population. Br J Dermatol. 1998;138(3):422-425 (Pubitemid 28145508)
3. Garbe C, Buttner P, Weiss J, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994;102(5):700-705 (Pubitemid 24144246)
4. Dennis LK, White E, Lee JA, et al. Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol. 1996;143(3):248-256
5. Green A, Siskind V, Hansen ME, Leech P. Melanocytic nevi in schoolchildren in Queensland. J Am Acad Dermatol. 1989;20(6):1054-1060 (Pubitemid 19151514)
6. Darlington S, Siskind V, Green L, Green A. Longitudinal study of melanocytic nevi in adolescents. J Am Acad Dermatol. 2002;46(5):715-722
7. Gallagher RP, McLean DI, Yang CP, et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol. 1990;126(6):770-776 (Pubitemid 20193793)
8. Hammer H, Tóth-Molnár E, OláH J, Dobozy A. Cutaneous dysplastic naevi: risk factor for uveal melanoma. Lancet. 1995;346(8969):255- 256
9. Barnhill RL, Mihm MC, Ceballos PI. Angiogenesis and regressing cutaneous malignant melanoma. Lancet. 1992;339(8799):991-992
10. Halpern AC, Guerry D, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol. 1991;127(7):995-999
11. Garbe C, Buttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994;102(5):695-699 (Pubitemid 24144245)
12. Slade J, Marghoob AA, Salopek TG, Rigel DS, Kopf AW, Bart RS. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol. 1995;32(3):479-494
13. Krüger S, Garbe C, Buttner P, et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol. 1992;26(6):920-926
14. GarbeC, Eigentler TK.Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res. 2007;17(2):117-127 (Pubitemid 46673905)
15. Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Ophthalmology. 2007;114(4):774-779 (Pubitemid 46505166)
16. Richtig E, Langmann G, Müllner K, Smolle J. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Ophthalmologica. 2004;218(2):111-114 (Pubitemid 38338474)
17. Csoma Z, Hencz P, Orvos H, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics. 2007;119(5):1036-1037 (Pubitemid 46715684)
18. Csoma Z, Hencz P, Orvos H, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics. 2007;119(6):1269 (Pubitemid 46871316)
19. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(9):920-928 (Pubitemid 351397091)
20. Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician. 2002;65(4):599-606
21. Dennery PA, Seidman DS, Stevenson DK, et al. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344(8):581-590
22. Bauer J, Buttner P, Luther H, et al. Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Arch Dermatol. 2004;140(4):493-494 (Pubitemid 38469263)
23. Matichard E, Le Hénanff A, Sanders A, Leguyadec J, Crickx B, Descamps V. Effect of neonatal phototherapy on melanocytic nevus count in children. Arch Dermatol. 2006;142(12):1599-1604 (Pubitemid 44969216)
24. MahÉ E, Bauchet A, Aegerter P, Saiag P. Neonatal blue-light phototherapy does not increase nevus count in 9-year-old children. Pediatrics. 2009;123(5). Available at: www.pediatrics.org/cgi/content/full/123/5/e896
25. Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer. 2008;122(12):2753-2760 (Pubitemid 351631377)
26. Kanetsky PA, Rebbeck TR, Hummer AJ, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 2006;66(18):9330-9337 (Pubitemid 44521156)
27. Bishop DT, Demenais F, Iles MM, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet. 2009;41(8):920-925
28. Hart PH, Jaksic A, Swift G, Norval M, el-Ghorr A, Finlay-Jones JJ. Histamine involvement in UVBand cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses. Immunology. 1997;91(4):601-608 (Pubitemid 27312344)
29. Beissert S, Rühlemann D, Mohammad T, et al. IL-12 prevents the inhibitory effects of cisurocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis. J Immunol. 2001;167(11):6232-6238 (Pubitemid 33081552)
30. Moodycliffe AM, Bucana CD, Kripke ML, Norval M, Ullrich SE. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation. J Immunol. 1996;157(7):2891-2899 (Pubitemid 126450044)
31. Welsh MM, Karagas MR, Applebaum KM, Spenser SK, Perry AE, Nelson HH. A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions. Carcinogenesis. 2008;29(10):1950- 1954
32. English DR, MacLennan R, Rivers JK, Kelly J, Armstrong BK. Epidemiological Studies of Melanocytic Nevi: Protocol for Identifying and Recording Nevi. Lyon, France: International Agency for Research on Cancer; 1990. Internal report 90/002
33. Shields JA. Diagnosis and Management of Intraocular Tumors. St Louis, MO: CV Mosby; 1983
34. Széll M, Baltas E, Bodai L, et al. The Arg160Trp allele of melanocortin-1 receptor gene might protect against vitiligo. Photochem Photobiol. 2008;84(3):565-571 (Pubitemid 351589370)
35. Csoma Z, Kemeny L, Olah J. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(23):2523-2524 (Pubitemid 351793052)
36. Imesch PD, Wallow IH, Albert DM, et al. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. Surv Ophthalmol. 1997;41(suppl 2):S117-S123 (Pubitemid 27154535)
37. Bito LZ, Matheny A, Cruickshanks KJ, et al. Eye color changes past early childhood: the Louisville Twin Study. Arch Ophthalmol. 1997;115(5):659-663
38. Chin KC, Moseley MJ, Bayliss SC, et al. Light transmission of phototherapy eyeshields. Arch Dis Child. 1987;62(9):970-971 (Pubitemid 17154311)
39. Moseley H, Marshall J. Protective light shields for neonatal phototherapy. Lancet. 1988;2(8615):854-855
40. Fok TF, Wong W, Cheung KL. Eye protection for newborns under phototherapy: comparison between a modified headbox and the conventional eyepatches. Ann Trop Paediatr. 1997;17(4):349-354 (Pubitemid 27511118)
41. Ostrowski G, Pye SD, Laing IA, et al. Do phototherapy hoods really protect the neonate? Acta Paediatr. 2000;89(7):874-877 (Pubitemid 30622590)
42. Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol. 2004;49(4):419-428 (Pubitemid 38844800)
43. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology. 2005;112(9):1599-1607 (Pubitemid 41725419)